FDA Approved: ALPHAGAN P — Supplemental Application (Allergan, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Alphagan P (brimonidine tartrate) from Allergan, indicating a modification or addition to the existing NDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma
• Ocular Hypertension

Drugs mentioned

• ALPHAGAN P (BRIMONIDINE TARTRATE)

Snippet

SUPPL AP for ALPHAGAN P (BRIMONIDINE TARTRATE)